Hemangioblastoma: Symptoms, Causes, Treatment & Complete Guide
Updated: 1 day ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
A hemangioblastoma is a rare, slow-growing, noncancerous tumor that starts in blood-vessel-forming cells in the brain, spinal cord or eye. Symptoms depend on location. About 1 in 4 is linked to von Hippel-Lindau disease. MRI with contrast is the main test, and surgery is the main treatment, usually offering a lasting cure for sporadic tumors.
What the research says
Focused radiation controlled most hemangioblastomas. A meta-analysis of 28 studies (627 patients, 1,761 lesions) of stereotactic radiosurgery for central nervous system hemangioblastomas found pooled local tumor control of 87% at 5 years (95% CI 82–91%) and 80% at 10 years (95% CI 63–91%). At 5 years, control was higher for VHL-associated lesions (94%) than for sporadic tumors (82%), and pooled adverse events were 11%. (Zare et al., Neurosurg Rev, 2025) [3]
The targeted medicine belzutifan showed activity against VHL-related hemangioblastomas. In a phase 2 trial in people with VHL disease, central nervous system hemangioblastomas responded in 15 of 50 patients (30%), and all 16 evaluable eyes (12 patients) with retinal hemangioblastomas were graded as improved. The most common adverse events were anemia (90% of patients) and fatigue (66%). (Jonasch et al., N Engl J Med, 2021) [4]
Photodynamic therapy controlled most retinal hemangioblastomas. In a case series of 17 patients (18 tumors), photodynamic therapy achieved tumor control in 13 of 18 tumors (72%) and stable or improved visual acuity in 12 of 17 eyes (71%), with a transient exudative response in 4 of 17 eyes (24%). (Di Nicola et al., Ophthalmol Retina, 2022) [5]
Hemangioblastoma at a Glance
Aspect | Summary |
Definition | Rare, slow-growing, benign tumor starting in blood-vessel-forming cells of the brain, spinal cord, or retina |
Nature | Noncancerous — does not spread; WHO grade 1 |
Most common location | Cerebellum |
Typical age | Midlife (40s–50s); late 20s–30s when linked to VHL disease |
Genetic link | About 1 in 4 tumors tied to von Hippel-Lindau (VHL) disease |
Signature feature | Often forms a fluid-filled cyst that raises pressure and worsens symptoms |
Main test | MRI with contrast — tumor appears as a bright round spot next to a pocket of fluid |
Main treatment | Surgery to remove the whole tumor and cyst wall — usually a lasting cure for sporadic tumors |
Other options | Preoperative embolization, focused radiation (85–90% control at 5 years), belzutifan for VHL cases |
Outlook | Generally good — most people remain tumor-free for many years after complete removal |
What Is a Hemangioblastoma?
A hemangioblastoma is a rare, slow-growing tumor that starts in the cells that form blood vessels in the brain, spinal cord, or part of the eye. These tumors are noncancerous, also called benign — unlike cancers, they do not spread to other parts of the body.
A few naming points help clarify what this tumor is (and isn't):
Term | What It Means |
Hemangioblastoma | The benign blood-vessel tumor of the brain, spinal cord, or eye — formerly called angioblastoma |
Hemangioma | A different condition — a common birthmark or blood vessel growth that usually appears in the skin or soft tissue and does not involve the brain or spinal cord |
WHO grade 1 | The classification these tumors carry — benign and slow-growing; there is no TNM cancer-staging system for them (TNM describes tumor size and spread to lymph nodes or distant organs, which doesn't apply here) |
The tumor most often appears in midlife, typically in the 40s or 50s — but it tends to occur earlier, often in the late 20s to 30s, in people with von Hippel-Lindau (VHL) disease. It is very uncommon in children, and it occurs slightly more often in men than in women.
These tumors are uncommon. Hemangioblastomas make up about 2 out of every 100 brain tumors and about 2 out of every 100 spinal tumors, and retinal hemangioblastomas affect about 1 in 73,000 people. [6]
Where Hemangioblastomas Grow — and the Symptoms Each Location Causes
Symptoms depend on where the tumor grows and whether it puts pressure on nearby nervous system structures. The most common locations and their typical symptoms:
Location | Symptoms |
Cerebellum and brain | Headache, dizziness, nausea, vomiting, trouble with balance or coordination |
Brainstem | Trouble swallowing, double vision or trouble with eye movement, slurred speech, facial weakness, walking that is not steady |
Spinal cord | Neck or back pain, weakness, numbness or tingling, trouble with bladder or bowel function |
Retina (the light-sensing layer at the back of the eye) | Blurry vision or vision loss |
Retinal tumors can also cause flashes of light, floaters or a darkening of vision, as well as eye pain and swelling. [6]
The Cyst Effect: Why Symptoms Can Worsen Quickly
Many hemangioblastomas form fluid-filled sacs called cysts when fluid leaks from the tumor into nearby tissue. As a cyst expands, it raises pressure inside the head or spine — and this pressure makes symptoms worse and causes the disease to progress more quickly. Symptoms may appear suddenly if there is pressure on nerves, blocked fluid flow, swelling, or (less often) bleeding.
When to Seek Care
Get medical help right away for sudden or severe symptoms that may signal bleeding or blocked fluid flow in the brain or spine. These can include:
Emergency Sign | What to Watch For |
Sudden intense headache | A headache that feels different from a typical headache |
Pressure signs | Repeated vomiting, confusion, or sudden drowsiness |
Vision and face | Double vision, new vision loss, or facial drooping |
Movement changes | New or fast-worsening weakness, numbness, or trouble walking |
Loss of control | Loss of bladder or bowel function |
Contact your care team soon for milder symptoms that keep getting worse — such as trouble with balance, ongoing headaches, or gradual changes in vision, coordination, or limb strength.
Causes: Sporadic or Inherited?
The cause of hemangioblastoma depends on whether the tumor develops on its own or as part of an inherited condition.
Most hemangioblastomas happen for no known reason and are called sporadic — these tumors are not passed down through families.
About 1 in 4 hemangioblastomas is linked to a genetic condition called von Hippel-Lindau (VHL) disease. This condition occurs when a person is born with a change (mutation) in the VHL gene — the gene that normally helps control cell growth and blood vessel formation. When it doesn't work correctly, extra blood vessels can grow and form tumors in the brain, spinal cord, eyes, and other organs. Only tumors caused by VHL disease can be inherited from a parent who carries the gene change.
People with VHL disease have about an 8 in 10 chance of developing a hemangioblastoma in the brain or spine, and up to 6 in 10 may have a retinal hemangioblastoma. [6]
In people without VHL disease, similar gene changes can happen later in life inside the tumor itself — these are called somatic mutations, and they affect only the tumor, not the rest of the body. Researchers believe that when the VHL gene stops working properly, it allows certain proteins that promote blood vessel growth to build up — and this process may lead to a hemangioblastoma over time.
Risk Factors
Most people with hemangioblastoma have no known risk factors. There are no lifestyle, environmental, or behavioral factors known to cause it. The key points:
Factor | What the Evidence Shows |
Von Hippel-Lindau (VHL) disease | The main risk factor — an inherited condition that causes tumors and cysts in several body parts. People with VHL have a much higher chance of one or more hemangioblastomas, though having VHL doesn't always mean a tumor will form |
Age of onset | VHL-related tumors appear earlier (late 20s–30s); sporadic tumors usually occur between ages 30 and 60 |
Sex | Occurs slightly more often in men than in women; sporadic tumors affect all genders at about the same rate |
Lifestyle factors | None known to play a role |
Because hemangioblastoma can run in families affected by VHL disease, genetic testing and counseling are recommended for people who have more than one hemangioblastoma, a family history of VHL disease or VHL-related tumors, or a hemangioblastoma diagnosed before age 50.
Complications: What Makes a Benign Tumor Serious
Although hemangioblastomas are benign, they can cause serious complications if they grow, bleed, or block fluid flow in the brain or spinal cord:
Complication | How It Happens and What It Does |
Cyst formation | The most common issue — a fluid-filled sac raises pressure inside the head or spine, worsening headache, nausea, and balance trouble |
Hydrocephalus | As pressure builds, fluid collects in the brain — leading to headache, vomiting, vision changes, and unsteady walking |
Hemorrhage | Bleeding within the tumor, occurring suddenly — may cause a severe headache, rapid loss of coordination, or lessened alertness |
Nerve damage or compression | Tumors in the cerebellum or spinal cord can damage or compress nearby nervous system pathways — causing weakness, numbness, and balance and coordination difficulty |
Vision loss | Retinal tumors can cause vision loss from bleeding or retinal detachment |
Prevention
There is no known way to prevent a hemangioblastoma — most tumors occur without any clear cause, and lifestyle factors do not appear to play a role.
For people with VHL disease, regular screening and imaging help detect hemangioblastomas and other tumors early and lower the risk of serious complications. These checkups often include a brain MRI, imaging scans of the spinal cord and abdomen, and eye exams to look for retina changes. Family members of someone diagnosed with VHL disease may also benefit from genetic counseling or testing to learn whether they carry the same gene change — identifying VHL disease early allows for careful monitoring and treatment before tumors cause symptoms.
How Is Hemangioblastoma Diagnosed?
Diagnosis usually begins with a medical history, general physical exam, and neurological exam. The care team reviews symptoms such as headache, vision changes, weakness, and balance trouble, and checks reflexes, coordination, eye movement, and muscle strength for signs of pressure on the brain or spinal cord. An eye check looking at the back of the eye is done when vision is affected. Imaging tests then confirm the diagnosis and guide care:
Test | What It Is and What It Shows |
MRI with contrast (the main test) | A powerful magnet and radio waves create detailed 3D pictures of the brain or spinal cord, with a contrast given through a vein so the tumor stands out. Shows both solid and fluid-filled parts of the tumor and its blood supply — the tumor often looks like a bright round spot next to a pocket of fluid. Radiologists can often tell a hemangioblastoma from other tumors (like pilocytic astrocytoma or cavernous hemangioma) by these imaging characteristics |
CT scan | X-rays plus computer processing create cross-sectional images; sometimes uses contrast. Used if MRI isn't available or as an additional view — shows size, location, calcium, or bleeding, though small tumors near bone can be hard to see and it's less detailed for the back of the brain |
Cerebral angiogram | Contrast and X-rays map the arteries feeding the tumor — used if MRI isn't possible or when planning surgery |
Biopsy or surgical diagnosis | If imaging is unclear, tissue is removed and examined under a microscope — the exam shows a dense network of blood vessels and distinctive stromal cells (supportive cells containing fat and fluid), often testing positive for a marker called inhibin A — confirming hemangioblastoma |
Genetic testing | VHL testing is recommended when a person has more than one tumor or is diagnosed before age 50; results guide screening for tumors in the brain, spine, eyes, and abdomen |
Treatment: Removing the Tumor and Easing the Pressure
Treatment focuses on safely removing or controlling the tumor and easing pressure on nearby brain or spinal cord tissue. The best approach depends on the tumor's size, location, and whether it's linked to VHL disease. Note that these tumors can keep growing or return after surgery — especially in people with VHL disease, who may have more than one hemangioblastoma in the brain, spinal cord, or eyes over time.
Because these tumors grow slowly, a care team may recommend delaying surgery or other treatment for people who have no symptoms. [6]
Surgery and Procedures
Surgery is the main treatment for most hemangioblastomas. The goal is to remove the entire tumor, including any cyst wall, while protecting nearby brain or spinal cord tissue. Surgery relieves pressure, improves symptoms, and usually provides a lasting cure for sporadic tumors when complete removal is possible.
Even after successful surgery, the tumor may already have caused long-term problems such as nerve damage or vision loss. [6]
Option | What It Is |
Preoperative embolization | Done before surgery for some large or deep tumors — a catheter blocks the blood vessels feeding the tumor to reduce bleeding during removal, lowering surgical risk |
Radiation therapy | Focused beams of energy destroy tumor cells — including stereotactic radiosurgery, proton therapy, or external beam radiation. Helps control small or hard-to-reach tumors, or ones that return after earlier treatment. Long-term studies show focused radiosurgery controls tumor growth in most people — about 85% to 90% at five years — with few serious side effects |
Medicines, Follow-Up, and Rehabilitation
For people with VHL disease who develop multiple tumors, the newer targeted medicine belzutifan (Welireg) may help — it works by blocking a protein that helps tumors form new blood vessels, and it may slow or shrink VHL-related hemangioblastomas and reduce the need for repeated surgeries.
Ongoing care matters just as much as the initial treatment. Regular MRI scans check for new or returning tumors, especially in VHL disease, so changes are caught early — before symptoms or complications develop. And some people need rehabilitation after treatment: physical, occupational, or vision therapy to regain strength, balance, or coordination. Vision therapy, low vision aids, and orientation training help with lasting vision changes, while balance or vestibular therapy improves coordination and lessens dizziness.
Alternative Medicine: The Honest Boundary
There are no proven alternative or natural treatments for hemangioblastoma. Some integrative approaches used alongside standard care — gentle exercise, mindfulness, or relaxation techniques — may help with stress or fatigue and support well-being. But always talk with your care team before trying any integrative therapy or dietary supplement: some products can interact with treatments, be of poor quality, or cause harm if misused — and never replace recommended medical care with unproven alternatives. Options like dietary supplements or cannabis may pose specific risks.
Lifestyle and Home Support
No specific home treatments prevent or shrink a hemangioblastoma — but healthy habits support recovery after treatment:
Stay active safely. Gentle physical activity such as walking or stretching can improve balance and strength — ask your care team which exercises are safe for you.
Follow your care plan. Keep all scheduled MRI scans and appointments; regular imaging helps the team find changes early.
Manage stress. Mindfulness, breathing exercises, and relaxation techniques reduce anxiety and improve sleep.
Eat well. A balanced diet with enough protein, fruits, vegetables, and fluids supports healing after surgery or radiation.
Use support. Counseling, support groups, and online communities help you cope emotionally and stay motivated.
Coping and Support
Living with a rare tumor brings physical and emotional challenges — anxiety about treatment, recovery, and the chance of new tumors forming over time is common. Five strategies help you cope and feel more in control:
Strategy | What It Looks Like |
Learn about your condition | Understanding your diagnosis and treatment plan reduces fear and uncertainty — ask your team to explain anything unclear |
Stay connected | Talking with family, friends, or others who have VHL disease or a rare tumor helps you feel supported; online support groups offer connection |
Work with your care team | Report new or worsening symptoms or emotional changes — counseling, stress management, or rehabilitation can be part of your care |
Take care of yourself | Rest, good nutrition, gentle exercise, and mindfulness support recovery and mood |
Use practical support | Ask your team's social worker or care navigator about lodging, transportation, or financial assistance |
Having a long-term care plan and a team you trust makes living with hemangioblastoma easier — many people find strength in building a support network and focusing on the parts of life they can control.
Preparing for Your Appointment
You may start by seeing your primary healthcare professional if you have symptoms such as headache, trouble with balance, or vision changes — you'll likely be referred to a neurologist, neurosurgeon, or neuro-oncologist who specializes in conditions affecting the brain, spinal cord, or eyes.
What You Can Do
Write down your symptoms — when they began and how they've changed
Note any family history of VHL disease or similar tumors
Bring a list of all medicines, vitamins, and supplements you take
Ask a family member or friend to come along, if possible, to help remember information
Write down questions to ask your care team
Questions to Ask
What could be causing my symptoms?
What tests do I need?
What treatment options do I have?
If I have a hemangioblastoma, how large is it and where is it located?
What are the possible risks and benefits of each treatment?
Do I need to be screened for VHL disease?
Should my family members have genetic counseling or testing?
What type of follow-up will I need?
You can expect your care team to review your symptoms and imaging results, discuss treatment choices, and plan your next steps — with time to ask questions and learn what to expect before, during, and after treatment.
Frequently Asked Questions
What is a hemangioblastoma?
A hemangioblastoma is a rare, slow-growing tumor that starts in the cells that form blood vessels in the brain, spinal cord, or retina. It is benign (noncancerous) and does not spread to other parts of the body.
Is hemangioblastoma a brain cancer?
No. Hemangioblastomas are classified as WHO grade 1 — benign and slow-growing. Unlike cancers, they don't spread, so there's no TNM cancer-staging system for them.
What are the symptoms of a hemangioblastoma?
Symptoms depend on location: headache, dizziness, nausea, and balance trouble (cerebellum); swallowing trouble, double vision, slurred speech, and facial weakness (brainstem); neck or back pain, numbness, and bladder or bowel trouble (spinal cord); or blurry vision and vision loss (retina).
Is hemangioblastoma genetic?
About 1 in 4 hemangioblastomas is linked to von Hippel-Lindau (VHL) disease, an inherited VHL gene mutation. These tumors appear earlier (late 20s to 30s) and can recur. Most tumors, however, are sporadic with no known cause and aren't inherited.
How is hemangioblastoma diagnosed?
Diagnosis begins with a history, physical, and neurological exam, plus an eye check when vision is affected. The main test is an MRI with contrast — the tumor typically appears as a bright round spot next to a pocket of fluid. CT scans, cerebral angiograms, biopsy, and VHL genetic testing may also be used.
How is hemangioblastoma treated?
Surgery is the main treatment — removing the entire tumor and cyst wall usually provides a lasting cure for sporadic tumors. Other options include preoperative embolization, focused radiation (which controls growth in about 85–90% of cases at five years), and belzutifan, a targeted medicine for VHL-related tumors.
What is the outlook for hemangioblastoma?
After complete tumor removal, the long-term outlook is generally good, with most people remaining tumor-free for many years. Tumors can grow or return after surgery, especially in people with VHL disease, so regular MRI monitoring is important.
Conclusion
The three lessons to carry away from this guide:
Benign doesn't mean harmless: a hemangioblastoma never spreads like a cancer, but its location determines its danger — a small tumor pressing on the brainstem or spinal cord, or a cyst raising pressure, can cause serious symptoms that need prompt attention.
The 1-in-4 VHL rule changes the story: about a quarter of these tumors are tied to an inherited gene change, which means earlier onset, multiple tumors, possible recurrence — and a strong case for genetic testing and family screening.
Complete removal usually means lasting cure: surgery is the workhorse treatment and generally delivers a lasting cure for sporadic tumors, with radiation and the newer targeted medicine belzutifan covering the cases surgery can't reach.
This guide has walked you through what a hemangioblastoma is, the four locations and their symptom patterns, the cyst effect, the sporadic-versus-inherited cause story, the risk factors, the complications, the diagnostic path from neurological exam to MRI and genetic testing, the full treatment menu, and the support strategies that make living with a rare tumor easier.
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
Mayo Clinic Staff. Hemangioblastoma - Symptoms and causes. Mayo Clinic. February 4, 2026. https://www.mayoclinic.org/diseases-conditions/hemangioblastoma/symptoms-causes/syc-20594491
Mayo Clinic Staff. Hemangioblastoma - Diagnosis and treatment. Mayo Clinic. February 4, 2026. https://www.mayoclinic.org/diseases-conditions/hemangioblastoma/diagnosis-treatment/drc-20594505
Zare A, et al. Stereotactic radiosurgery in the management of central nervous system hemangioblastomas: a systematic review and meta-analysis. Neurosurg Rev. 2025;48(1):303. PMID 40091097. https://doi.org/10.1007/s10143-025-03454-9
Jonasch E, et al. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021;385(22):2036-2046. PMID 34818478. https://doi.org/10.1056/NEJMoa2103425
Di Nicola M, Williams BK, Hua J, et al. Photodynamic Therapy for Retinal Hemangioblastoma: Treatment Outcomes of 17 Consecutive Patients. Ophthalmol Retina. 2022;6(1):80-88. PMID 33892136. https://doi.org/10.1016/j.oret.2021.04.007
Cleveland Clinic. Hemangioblastoma. Cleveland Clinic. Last updated February 21, 2026. https://my.clevelandclinic.org/health/diseases/22738-hemangioblastoma
Comments